Document
IPR2023-00724, No. 2431 Exhibit - EX2431 US Food Drug Administration, DrugsFDA, Oseni® (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2431 Exhibit - EX2431 US Food Drug Administration, DrugsFDA, Oseni® (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2498 Exhibit - EX2498 Novo Nordisk, Financial report for the period 1 January 2019 to 31 March 2019 May 3, 2019 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2498 Exhibit - EX2498 Novo Nordisk, Financial report for the period 1 January 2019 to 31 March 2019 May 3, 2019 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2363 Exhibit - EX2363 US Food Drug Administration, DrugsFDA, Micronase® (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2363 Exhibit - EX2363 US Food Drug Administration, DrugsFDA, Micronase® (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2389 Exhibit - EX2389 Ho, PM, Bryson, CL, and Rumsfeld, JS, Medication Adherence, Circulation, 2009 119233028 3035 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2389 Exhibit - EX2389 Ho, PM, Bryson, CL, and Rumsfeld, JS, Medication Adherence, Circulation, 2009 119233028 3035 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2352 Exhibit - EX2352 Mayo Clinic, “Diabetes – Symptoms causes,” httpswwwmayoclinicorgdiseases conditionsdiabetessymptoms causessyc 20371444, last updated Sept...
Cite Document
IPR2023-00724, No. 2352 Exhibit - EX2352 Mayo Clinic, “Diabetes – Symptoms causes,” httpswwwmayoclinicorgdiseases conditionsdiabetessymptoms causessyc 20371444, last updated Sept 15, 2023 (P.T.A.B.
+ More Snippets
Document
IPR2023-00724, No. 2367 Exhibit - EX2367 Sirtori, CR and Pasik, C, Re evaluation of a biguanide, metformin mechanism of action and tolerability, Pharmacol Res 1994 Oct Nov 303187 228 (P....
Cite Document
IPR2023-00724, No. 2367 Exhibit - EX2367 Sirtori, CR and Pasik, C, Re evaluation of a biguanide, metformin mechanism of action and tolerability, Pharmacol Res 1994 Oct Nov 303187 228 (P.T.A.B. Jan.
+ More Snippets
Document
IPR2023-00724, No. 1090 Exhibit - Exhibit 1090 (P.T.A.B. Aug. 10, 2023)
Cite Document
IPR2023-00724, No. 1090 Exhibit - Exhibit 1090 (P.T.A.B. Aug. 10, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1131 Exhibit - Exhibit 1131 Form 6K 2011 (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1131 Exhibit - Exhibit 1131 Form 6K 2011 (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1122 Exhibit - Exhibit 1122 ADA Standards 2023 (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1122 Exhibit - Exhibit 1122 ADA Standards 2023 (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1125 Exhibit - Exhibit 1125 Pi Sunyer (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1125 Exhibit - Exhibit 1125 Pi Sunyer (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1097 Exhibit - Exhibit 1097 Garber 2009 (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1097 Exhibit - Exhibit 1097 Garber 2009 (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1129 Exhibit - Exhibit 1129 Cecil (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1129 Exhibit - Exhibit 1129 Cecil (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1119 Exhibit - Exhibit 1119 Trulicity label (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1119 Exhibit - Exhibit 1119 Trulicity label (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1127 Exhibit - Exhibit 1127 CLAIM CONSTRUCTION ORDER (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1127 Exhibit - Exhibit 1127 CLAIM CONSTRUCTION ORDER (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1101 Exhibit - Exhibit 1101 Ozempic Orange Book (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1101 Exhibit - Exhibit 1101 Ozempic Orange Book (P.T.A.B. May. 22, 2024)
+ More Snippets